Study Details

Back
Study ID 9766-CL-0105
Study Title A Phase III, Double-Blind, Randomized Study to Evaluate the Safety and Efficacy of BAL8557 Versus a Caspofungin Followed by Voriconazole Regimen in the Treatment of Candidemia and Other Invasive Candida Infections
Clinicaltrials.gov Identifier NCT00413218
Compound Name BAL8557 / isavuconazonium sulfate
Medical Indication or Disease Invasive fungal infection
Study Sponsor Astellas Pharma Global Development, Inc.
Collaborator Basilea Pharmaceutica International, Ltd.
Study Start Date 08-Mar-2007
Study Completion Date 03-Mar-2015
Clinical Study Result
Select the language
English
Plain Language Summary
Select the language
English

QUICK SEARCH

USEFUL LINKS